| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.30B | 2.00B | 1.91B | 2.25B | 2.92B | 2.74B |
| Gross Profit | 1.99B | 2.00B | 1.91B | 1.80B | 1.88B | 1.60B |
| EBITDA | 417.24M | 0.00 | 816.98M | 900.84M | 690.59M | 361.62M |
| Net Income | 698.73M | 693.48M | 941.04M | 804.87M | 516.20M | 268.34M |
Balance Sheet | ||||||
| Total Assets | 30.24B | 58.25B | 56.63B | 57.29B | 58.84B | 51.53B |
| Cash, Cash Equivalents and Short-Term Investments | 3.54B | 5.52B | 7.70B | 8.47B | 9.13B | 6.52B |
| Total Debt | 7.70B | 2.80B | 7.73B | 2.89B | 3.36B | 3.37B |
| Total Liabilities | 26.62B | 52.60B | 51.15B | 2.76B | 53.10B | 46.20B |
| Stockholders Equity | 5.30B | 5.66B | 5.47B | 4.88B | 5.20B | 4.76B |
Cash Flow | ||||||
| Free Cash Flow | 621.84M | -584.79M | -1.69B | -2.25B | -2.13B | -219.27M |
| Operating Cash Flow | 252.39M | -567.79M | -1.67B | -2.22B | -2.12B | -205.94M |
| Investing Cash Flow | -2.93B | 11.04M | -209.37M | -13.99M | 35.56M | 1.41M |
| Financing Cash Flow | -656.39M | -559.23M | 1.43B | 1.73B | 4.61B | -548.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £290.96M | 6.69 | 23.18% | 3.80% | 9.93% | -15.65% | |
68 Neutral | £11.47B | 3.32 | 12.75% | 6.78% | -2.34% | 2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | £34.06M | 13.98 | 3.68% | 7.96% | -9.55% | ― | |
58 Neutral | £121.91M | 3.75 | 4.98% | ― | 15.42% | ― | |
46 Neutral | £620.87M | -2.93 | -9.28% | ― | -15.79% | -211.91% |